Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition.
about
Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the HeadAntigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cellsRecycling MHC class I molecules and endosomal peptide loadingThe class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosolAn HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteinsDC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes.Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity.Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation.Measles virus-specific antibody levels in individuals in Argentina who received a one-dose vaccineEntrance and survival of Salmonella typhimurium and Yersinia enterocolitica within human B- and T-cell lines.Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5)Assembly and peptide binding of major histocompatibility complex class II heterodimers in an in vitro translation system.Trimming of antigenic peptides in an early secretory compartment.Presentation by a major histocompatibility complex class I molecule of nucleoprotein peptide expressed in two different genes of an influenza virus transfectantAntibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis.Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion proteinCombination vaccines: synergistic simultaneous induction of antibody and T-cell immunity.Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children.Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators.ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation.Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4⁺ T cells but are incapable of cross-presentation.Delivery of protein antigen to the major histocompatibility complex class I-restricted antigen presentation pathway.Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain.ISCOMs (immunostimulating complexes): the first decade.Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum.Major histocompatibility complex class II molecules induce the formation of endocytic MIIC-like structuresDendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading.Respiratory syncytial virus differentially activates murine myeloid and plasmacytoid dendritic cells.Influence of respiratory syncytial virus infection on cytokine and inflammatory responses in allergic mice.Both immunization with protein and recombinant vaccinia virus can stimulate CTL specific for the E7 protein of human papilloma virus 16 in H-2d mice.
P2860
Q26783897-01D9FF32-4152-4DD7-9AC5-BAD9CBEE2160Q28348352-7A1E5F1E-83F3-4126-8585-5EEE6DD6F70BQ28609669-23E14716-AA3D-4C94-B91F-889AE4FD1A6AQ30442820-0736C6FE-D847-4BBE-BC40-3D9C993AA5CDQ30442847-CB5934EC-08A2-4583-9389-496761A52FC2Q33329098-AAB1B803-FED7-4A1A-B4A9-DBA3DEC4FC37Q33659393-FDEF3B9F-595D-4DFC-B6F6-4415D587CD16Q33815400-DCD09858-D413-4A0D-BEE6-7733CBD9A456Q35073039-6A1D2797-A03F-4C6E-8CC7-F216A8EB4D5AQ35781760-9A09719E-454F-4AD3-A02E-A6A2CA818DEAQ35848231-FAB88777-B3BF-4B33-A05C-CBD33F5CC513Q35857485-1A8DB749-EED4-4A45-ACE4-5F1F67F2554FQ36364157-2B8BF45C-38C0-4972-9BCC-D61247EFB216Q36364290-44CB1209-DE1A-4CE0-87DC-316D1A6C28FFQ36628522-D3B3772D-72F1-46EF-A675-E00476F3FDDDQ36686798-9A69E3A0-66CC-47FB-9BB0-E603CC5272F0Q36728808-96FD92C0-3E80-4AC8-9F78-1E0E2ACB5FCFQ37388113-6E6581B1-37A3-4A99-967A-3E6B5C48941BQ37523971-A4463CFE-25B6-4DAF-9C3E-9671F996AE38Q37867098-969272A7-64DA-4DBD-B775-B49EBC06455EQ39510478-9ACA6FE9-E4F6-4AD3-92AD-68816E04DDE7Q40381395-9267DC23-F59D-4567-866E-A0A2175AC9B1Q40792165-24BAF018-AF8C-4C7B-A025-23CF91EFFA2CQ41231006-C79CCC1C-2A37-400D-8AA4-A963E4C455CFQ41354524-0CE9ED3D-94D9-478F-A1E5-1D03E2942415Q41450247-5E94CBC4-67AD-4EDA-B2B1-D4A077EC02F6Q41915734-15E2BF3E-59DD-4EE2-B09D-5F824F1EF0E0Q45404503-4966BECC-2656-40D5-AAF0-A59A1C0D70D0Q45732995-6D8F7A44-E26A-47B3-A3F0-793744F47F6FQ45790647-11BC6041-12EE-44C2-B76F-1B6A339590A6
P2860
Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Measles virus transmembrane fu ...... cytotoxic T cell recognition.
@ast
Measles virus transmembrane fu ...... cytotoxic T cell recognition.
@en
type
label
Measles virus transmembrane fu ...... cytotoxic T cell recognition.
@ast
Measles virus transmembrane fu ...... cytotoxic T cell recognition.
@en
prefLabel
Measles virus transmembrane fu ...... cytotoxic T cell recognition.
@ast
Measles virus transmembrane fu ...... cytotoxic T cell recognition.
@en
P2093
P2860
P921
P356
P1476
Measles virus transmembrane fu ...... cytotoxic T cell recognition.
@en
P2093
Cerundolo V
Osterhaus AD
UytdeHaag FG
de Vries P
van Baalen CA
van Binnendijk RS
P2860
P304
P356
10.1084/JEM.176.1.119
P407
P577
1992-07-01T00:00:00Z